Following injection, the metabolites of AOM accumulate in colonic cells and incite aberrant molecular and histological alterations that cause mucin depletion and formation of MDF, which are pre-malignant lesions frequently used as biomarkers for measuring the efficacy of chemopreventive agents in preclinical studies (34, 35). The gene discussed is MUC5AC; the disease is infectious otitis media.